Pituitary adenylate-cyclase-activating polypeptide (PACAP): another novel target for treatment of primary headaches?

Messoud Ashina^*, Paolo Martelletti

^*Corresponding author for this work

5 Citations (Scopus)

Access to Document

@article{09c8ad5a37e54b75808c1f93004b38b9,

title = "Pituitary adenylate-cyclase-activating polypeptide (PACAP): another novel target for treatment of primary headaches?",

author = "Messoud Ashina and Paolo Martelletti",

year = "2018",

doi = "10.1186/s10194-018-0860-4",

language = "English",

volume = "19",

pages = "33",

journal = "Journal of Headache and Pain",

issn = "1129-2369",

publisher = "SpringerOpen",

number = "1",

}

TY - JOUR

T1 - Pituitary adenylate-cyclase-activating polypeptide (PACAP)

T2 - another novel target for treatment of primary headaches?

AU - Ashina, Messoud

AU - Martelletti, Paolo

PY - 2018

Y1 - 2018

UR - https://www.scopus.com/pages/publications/85046659430

U2 - 10.1186/s10194-018-0860-4

DO - 10.1186/s10194-018-0860-4

M3 - Editorial

C2 - 29740710

AN - SCOPUS:85046659430

SN - 1129-2369

VL - 19

SP - 33

JO - Journal of Headache and Pain

JF - Journal of Headache and Pain

IS - 1

ER -